{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T18:24:20Z","timestamp":1761675860526},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2011,6,15]],"date-time":"2011-06-15T00:00:00Z","timestamp":1308096000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Abdom Imaging"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1007\/s00261-011-9755-4","type":"journal-article","created":{"date-parts":[[2011,6,14]],"date-time":"2011-06-14T19:26:35Z","timestamp":1308079595000},"page":"677-683","source":"Crossref","is-referenced-by-count":17,"title":["Current concepts in transarterial chemoembolization of hepatocellular carcinoma"],"prefix":"10.1007","volume":"36","author":[{"given":"Peter","family":"Huppert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,6,15]]},"reference":[{"key":"9755_CR1","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","volume":"55","author":"DM Parkin","year":"2005","unstructured":"Parkin DM, Bray F, Ferlay J, et al. (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74\u2013108","journal-title":"CA Cancer J Clin"},{"issue":"Suppl","key":"9755_CR2","doi-asserted-by":"crossref","first-page":"S169","DOI":"10.1016\/S1051-0443(07)61783-7","volume":"13","author":"AM Di Bisceglie","year":"2002","unstructured":"Di Bisceglie AM (2002) Epidemiology and clinical presentation of hepatocellular carcinoma. J Vasc Interv Radiol 13(Suppl):S169\u2013S171","journal-title":"J Vasc Interv Radiol"},{"key":"9755_CR3","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1055\/s-2007-1007117","volume":"19","author":"FX Bosch","year":"1999","unstructured":"Bosch FX, Ribes J, Borras J (1999) Epidemiology of primary liver cancer. Semin Liver Dis 19:271\u2013285","journal-title":"Semin Liver Dis"},{"issue":"7","key":"9755_CR4","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/ncponc0844","volume":"4","author":"M Schwartz","year":"2007","unstructured":"Schwartz M, Roayaie S, Konstadoulakis M (2007) Strategies for the management of hepatocellular carcinoma. Nat Clin Pract Oncol 4(7):424\u2013432","journal-title":"Nat Clin Pract Oncol"},{"key":"9755_CR5","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/S0140-6736(03)14964-1","volume":"362","author":"JM Llovet","year":"2003","unstructured":"Llovet JM, Burroughs A, Bruix J (2003) Hepatocellular carcinoma. Lancet 362:1907\u20131917","journal-title":"Lancet"},{"issue":"Suppl","key":"9755_CR6","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1148\/rg.25si055507","volume":"25","author":"HP Clark","year":"2005","unstructured":"Clark HP, Carson WF, Kavanagh PV, et al. (2005) Staging and current treatment of hepatocellular carcinoma. Radiographics 25(Suppl):S3\u2013S23","journal-title":"Radiographics"},{"issue":"5 Suppl","key":"9755_CR7","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1053\/j.gastro.2004.09.032","volume":"125","author":"J Bruix","year":"2004","unstructured":"Bruix J, Sala M, Llovet JM (2004) Chemoembolization for hepatocellular carcinoma. Gastroenterology 125(5 Suppl):179\u2013188","journal-title":"Gastroenterology"},{"key":"9755_CR8","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.jvir.2010.03.005","volume":"21","author":"BC Wible","year":"2010","unstructured":"Wible BC, Rilling WS, Drescher P, et al. (2010) Longitudinal quality of life assessment of patients with hepatocellular carcinoma after primary transarterial chemoembolization. J Vasc Interv Radiol 21:1024\u20131030","journal-title":"J Vasc Interv Radiol"},{"key":"9755_CR9","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/S0140-6736(02)08649-X","volume":"359","author":"JM Llovet","year":"2002","unstructured":"Llovet JM, Real MI, Montana X, et al. (2002) Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomized controlled trial. Lancet 359:1734\u20131739","journal-title":"Lancet"},{"key":"9755_CR10","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1053\/jhep.2002.33156","volume":"35","author":"CM Lo","year":"2002","unstructured":"Lo CM, Ngan H, Tso WK, et al. (2002) Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 35:1164\u20131171","journal-title":"Hepatology"},{"key":"9755_CR11","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1056\/NEJM199505113321903","volume":"332","author":"JC Trinchet","year":"1995","unstructured":"Trinchet JC, et al. (1995) A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma (Group d etude et de traitement du carcinoma hepatocellulaire). N Engl J Med 332:1256\u20131261","journal-title":"N Engl J Med"},{"key":"9755_CR12","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s00270-009-9697-1","volume":"33","author":"S Miyayama","year":"2010","unstructured":"Miyayama S, Yamashiro M, Okuda M, et al. (2010) The march of extrahepatic collaterals: analysis of blood supply to hepatocellular carcinoma located in the bare area of the liver after chemoembolization. CardioVasc Intervent Radiol 33:513\u2013522","journal-title":"CardioVasc Intervent Radiol"},{"key":"9755_CR13","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s00270-006-0062-3","volume":"30","author":"L Marelli","year":"2007","unstructured":"Marelli L, Stigliano R, Triantos C, et al. (2007) Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies. CardioVasc Interv Radiol 30:6\u201325","journal-title":"CardioVasc Interv Radiol"},{"key":"9755_CR14","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, et al. (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45:228\u2013247","journal-title":"Eur J Cancer"},{"key":"9755_CR15","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0168-8278(01)00130-1","volume":"35","author":"J Bruix","year":"2001","unstructured":"Bruix J, Sherman M, Llovet JM, et al. (2001) Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the study of the liver. J Hepatol 35:421\u2013430","journal-title":"J Hepatol"},{"key":"9755_CR16","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jhep.2008.01.022","volume":"48","author":"MJ Llovet","year":"2008","unstructured":"Llovet MJ, Bruix J (2008) Novel advancements in the management of hepatocellular carcinoma in 2008. J Hepatol 48:20\u201337","journal-title":"J Hepatol"},{"key":"9755_CR17","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1055\/s-2004-812776","volume":"176","author":"P Huppert","year":"2004","unstructured":"Huppert P, Lauchart W, Duda SH, et al. (2004) Chemoembolization of hepatocellular carcinoma: which factors determine therapeutic response and survival? Fortschr Roentgenstr 176:375\u2013385","journal-title":"Fortschr Roentgenstr"},{"key":"9755_CR18","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1007\/s10856-007-3068-8","volume":"18","author":"AL Lewis","year":"2007","unstructured":"Lewis AL, Gonzales MV, Leppard SW, et al. (2007) Doxorubicin eluting beads-1: effects of drug loading on beads characteristics and drug distribution. J Mater Sci Mater Med 18:1691\u20131696","journal-title":"J Mater Sci Mater Med"},{"key":"9755_CR19","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.jvir.2010.02.042","volume":"21","author":"O Jordan","year":"2010","unstructured":"Jordan O, Denys A, De Baere T, et al. (2010) Comparative study of chemoembolization loadable beads: in vitro drug release and physical properties of DC bead on hepasphere loaded with doxorubicin and irinotecan. J Vasc Interv Radiol 21:1084\u20131090","journal-title":"J Vasc Interv Radiol"},{"key":"9755_CR20","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.cgh.2007.04.021","volume":"5","author":"RT Poon","year":"2007","unstructured":"Poon RT, Tso WK, Pang RW, et al. (2007) A phase I\/II trial of chemoembolisation for hepatocellular carcinoma using a novel intraarterial drug-eluting bead. Clin Gastroenterol Hepatol 5:1100\u20131108","journal-title":"Clin Gastroenterol Hepatol"},{"key":"9755_CR21","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.jhep.2006.10.020","volume":"46","author":"M Varela","year":"2007","unstructured":"Varela M, Real MI, Burrel M, et al. (2007) Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics. J Hepatol 46:474\u2013481","journal-title":"J Hepatol"},{"key":"9755_CR22","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00270-009-9750-0","volume":"33","author":"K Malagari","year":"2010","unstructured":"Malagari K, Pomoni M, Kelekis A, et al. (2010) Prospective randomized comparison of chemoembolization with Doxorubicin-eluting beads and bland embolization with BeadBlock for hepatocellular carcinoma. Cardiovasc Intervent Radiol 33:541\u2013551","journal-title":"Cardiovasc Intervent Radiol"},{"key":"9755_CR23","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00270-009-9711-7","volume":"33","author":"J Lammer","year":"2010","unstructured":"Lammer J, Malagari K, Vogl T, et al. (2010) Prospective randomized study of doxorubicin-eluting bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study. Cardiovasc Interv Radiol 33:41\u201352","journal-title":"Cardiovasc Interv Radiol"},{"key":"9755_CR24","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1007\/s00270-008-9409-2","volume":"31","author":"M Grosso","year":"2008","unstructured":"Grosso M, Vignali C, Quaretti P, et al. (2008) Transarterial chemoembolization for hepatocellular carcinoma with drug-eluting microspheres: preliminary results from an Italian multicentre study. Cardiovasc Intervent Radiol 31:1141\u20131149","journal-title":"Cardiovasc Intervent Radiol"},{"key":"9755_CR25","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/jso.21522","volume":"101","author":"R Dhanasekaran","year":"2010","unstructured":"Dhanasekaran R, Kooby DA, Staley CA, et al. (2010) Comparison of conventional transarterial chemoembolization (TACE) and chemoembolization with doxorubicin drug eluting beads (DEB) for unresectable hepatocellular carcinoma (HCC). J Surg Oncol 101:476\u2013480","journal-title":"J Surg Oncol"},{"key":"9755_CR26","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1007\/s00270-009-9752-y","volume":"33","author":"G Bonomo","year":"2010","unstructured":"Bonomo G, Pedicini V, Monfardini L, et al. (2010) Bland embolization in patients with unresectable hepatocellular carcinoma using precise, tightly size-calibrated, anti-inflammatory microparticles: first clinical experience and one-year follow-up. Cardiovasc Intervent Radiol 33:552\u2013559","journal-title":"Cardiovasc Intervent Radiol"},{"key":"9755_CR27","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.jvir.2008.01.011","volume":"19","author":"S Stampfl","year":"2008","unstructured":"Stampfl S, Bellemann N, Stampfl U, et al. (2008) Inflammation and recanalization of four different spherical embolization agents in the porcine kidney model. J Vasc Interv Radiol 19:577\u2013586","journal-title":"J Vasc Interv Radiol"}],"container-title":["Abdominal Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-011-9755-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00261-011-9755-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-011-9755-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,20]],"date-time":"2020-06-20T03:49:26Z","timestamp":1592624966000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00261-011-9755-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6,15]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["9755"],"URL":"https:\/\/doi.org\/10.1007\/s00261-011-9755-4","relation":{},"ISSN":["0942-8925","1432-0509"],"issn-type":[{"value":"0942-8925","type":"print"},{"value":"1432-0509","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,15]]}}}